Anika Therapeutics ANIK Business Segments
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| Revenue by Product | ||||||
| Commercial Channel | $49.73M+13.5% | $48.41M+14.9% | $46.04M+14.4% | $43.87M+11.1% | $43.82M+19.5% | |
| OEM Channel | $66.53M-9.1% | $64.41M-17.2% | $66.76M-15.8% | $70.68M-12.4% | $73.23M-11.7% | |
| Revenue by Geography | ||||||
| Europe | $23.08M+11.9% | $22.21M+14.5% | $20.55M+31.5% | $19.68M+21.0% | $20.64M+27.3% | |
| Other Location | $20.95M+16.5% | $20.55M+13.8% | $19.13M+38.6% | $18.6M+25.4% | $17.98M+14.7% | |
| US | $72.27M-7.9% | $70.14M-15.0% | $73.17M+19.8% | $76.31M+7.0% | $78.47M-6.7% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How does Anika Therapeutics break its business down?
- Anika Therapeutics (ANIK) reports revenue by product across 2 parts — Commercial Channel and OEM Channel. Each is extracted from the segment footnotes and tracked over time.
- Where does Anika Therapeutics's segment data come from?
- Segment breakdowns are pulled from the segment footnotes in Anika Therapeutics's SEC filings (the XBRL dimensional tags), so every line ties back to a reported figure. Switch between quarterly, annual, and TTM, or open any segment for its full history.
